Induction Healthcare Group (INHC) Competitors GBX 9.75 0.00 (0.00%) As of 06/18/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock INHC vs. RENX, COG, FDBK, IQAI, TRLS, DVRG, SENS, EMIS, CRW, and INSShould you be buying Induction Healthcare Group stock or one of its competitors? The main competitors of Induction Healthcare Group include Renalytix (RENX), Cambridge Cognition (COG), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), and Instem (INS). These companies are all part of the "health information services" industry. Induction Healthcare Group vs. Its Competitors Renalytix Cambridge Cognition Feedback IQ-AI Trellus Health DeepVerge Sensyne Health EMIS Group Craneware Instem Induction Healthcare Group (LON:INHC) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends. Is INHC or RENX more profitable? Induction Healthcare Group has a net margin of -40.70% compared to Renalytix's net margin of -1,191.75%. Renalytix's return on equity of 293.20% beat Induction Healthcare Group's return on equity.Company Net Margins Return on Equity Return on Assets Induction Healthcare Group-40.70% -26.97% -7.32% Renalytix -1,191.75%293.20%-93.54% Does the media prefer INHC or RENX? In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score. Company Overall Sentiment Induction Healthcare Group Neutral Renalytix Neutral Which has better valuation and earnings, INHC or RENX? Induction Healthcare Group has higher revenue and earnings than Renalytix. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInduction Healthcare Group£12.57M0.72-£5.12M-£5.54-1.76Renalytix£9.22M3.08-£109.93M-£21.19-0.32 Which has more risk & volatility, INHC or RENX? Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500. Do insiders and institutionals believe in INHC or RENX? 46.3% of Induction Healthcare Group shares are held by institutional investors. Comparatively, 28.4% of Renalytix shares are held by institutional investors. 54.6% of Induction Healthcare Group shares are held by company insiders. Comparatively, 35.7% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryInduction Healthcare Group beats Renalytix on 7 of the 11 factors compared between the two stocks. Get Induction Healthcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INHC vs. The Competition Export to ExcelMetricInduction Healthcare GroupHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£9.00M£221.60M£5.53B£3.01BDividend YieldN/A6.68%5.06%5.02%P/E Ratio-1.76389.2628.58160.66Price / Sales0.72222.07371.58293,821.70Price / Cash2.6847.1424.7227.97Price / Book0.505.268.264.68Net Income-£5.12M-£15.55M£3.19B£5.90B7 Day PerformanceN/A0.71%5.16%7.26%1 Month Performance1.56%0.51%9.11%12.68%1 Year Performance-2.50%14.10%30.07%62.03% Induction Healthcare Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INHCInduction Healthcare GroupN/AGBX 9.75flatN/A-2.5%£9.00M£12.57M-1.7674RENXRenalytixN/AGBX 70.0%N/A-44.4%£29.01M£9.22M-0.33102Gap DownHigh Trading VolumeCOGCambridge CognitionN/AGBX 33+3.1%N/A-24.4%£13.82M£15.64M-8.7780Gap UpFDBKFeedbackN/AGBX 14.30-1.4%N/A-77.4%£6.27M£3.88M-0.5824Positive NewsIQAIIQ-AIN/AGBX 0.80flatN/A-27.3%£1.77M£538.19K-13.676Gap UpTRLSTrellus HealthN/AGBX 0.65flatN/A-67.7%£1.26M£65.83K-0.1931DVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AN/AN/AN/A£583K£7.81M-0.0270Negative NewsGap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware2.4002 of 5 starsGBX 2,200+0.5%GBX 2,800+27.3%-4.3%£945.27M£230.77M81.28734INSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500 Related Companies and Tools Related Companies Renalytix Alternatives Cambridge Cognition Alternatives Feedback Alternatives IQ-AI Alternatives Trellus Health Alternatives DeepVerge Alternatives Sensyne Health Alternatives EMIS Group Alternatives Craneware Alternatives Instem Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:INHC) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Induction Healthcare Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Induction Healthcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INHC Stock Alerts